tata v12 statistical software (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
tata v12 statistical software
Tata V12 Statistical Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tata+v12+statistical+software/STATA+12%2E0/pm38350818-32-5-9
Average 99 stars, based on 36686 article reviews
Tata V12 Statistical Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tata+v12+statistical+software/STATA+12%2E0/pm38350818-32-5-9
Average 99 stars, based on 36686 article reviews
tata v12 statistical software - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Software:Article Title: Determinants of COVID-19 Hospitalization Costs in a Referral Hospital for Respiratory Diseases. Article Snippet: The impact of the COVID-19 pandemic on deaths, sequelae, and excess mortality has been reported.. However, fewer reports on hospitalization costs are available, and they usually focus on the average cost for a general ward, the intensive care unit, and the emergency room.1–3 Fewer studies have described possible additional determinants of hospitalization costs.1–5 The main described factors increasing the hospital cost in COVID-19 patients included age, sex, the disease severity, and the presence of comorbidities, in addition to those considered standards such as the length of stay (LoS) in the hospital and the type of ward and support received, being highest in the intensive care unit (ICU), and for those requiring invasive mechanical ventilation (IMV).4–9 Hospitalization costs have a wide variability at the international level; the highest average costs have been reported in Saudi Arabia ($11,849) and the United States (U.S.) ($11,267 and 24,571).2,3,10 In Ethiopia and China ($1453–$6827), the lowest mean costs have been reported so far.4,5,11,12 Stratifying by severity, in Kenya, the average costs of severe and critical cases were USD 1949 and USD 7194, respectively.13 In Brazil, a mild case was estimated at USD$1975, a severe case USD$11,338, and a death in $12,993.1 In European studies, diabetes mellitus and obesity were positively associated with hospitalization costs in COVID-19 patients.14,15 Regarding the clinical determinants, age increased the mean cost by 0.9–85%, the length of stay by 4.7–4.9%, and the mechanical ventilation by 25% or up to 2.7 times.4,5,8 Likewise, the number of comorbidities increased the costs between 11 and 24%.8 In Mexico, 7.63 million confirmed cases of SARS-CoV-2 were registered until June 2023, of which 9.57% required hospitalization.. The present study was conducted at the Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas” in Mexico City. |